These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fenfluramine's appetite suppression and serotonin neurotoxicity are separable. McCann UD; Yuan J; Ricaurte GA Eur J Pharmacol; 1995 Sep; 283(1-3):R5-7. PubMed ID: 7498296 [TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drug. McCann UD; Yuan J; Hatzidimitriou G; Ricaurte GA J Pharmacol Exp Ther; 1997 Jun; 281(3):1487-98. PubMed ID: 9190887 [TBL] [Abstract][Full Text] [Related]
5. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain. McCann UD; Yuan J; Ricaurte GA Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127 [TBL] [Abstract][Full Text] [Related]
6. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
7. Interaction of phentermine plus fenfluramine: neurochemical and neurotoxic effects. Halladay AK; Fisher H; Wagner GC Neurotoxicology; 1998 Apr; 19(2):177-83. PubMed ID: 9553954 [TBL] [Abstract][Full Text] [Related]
8. Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine. Hatzidimitriou G; Tsai EH; McCann UD; Ricaurte GA Synapse; 2002 Apr; 44(1):51-7. PubMed ID: 11842446 [TBL] [Abstract][Full Text] [Related]
9. d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms. Garattini S; Samanin R Int J Obes; 1984; 8 Suppl 1():151-7. PubMed ID: 6534892 [TBL] [Abstract][Full Text] [Related]
10. Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system. Garattini S; Mennini T; Bendotti C; Invernizzi R; Samanin R Appetite; 1986; 7 Suppl():15-38. PubMed ID: 2427023 [TBL] [Abstract][Full Text] [Related]
11. Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential. Cozzi NV; Frescas S; Marona-Lewicka D; Huang X; Nichols DE Pharmacol Biochem Behav; 1998 Mar; 59(3):709-15. PubMed ID: 9512076 [TBL] [Abstract][Full Text] [Related]
12. Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration. Winsauer PJ; McCann UD; Yuan J; Delatte MS; Stevenson MW; Ricaurte GA; Moerschbaecher JM Psychopharmacology (Berl); 2002 Feb; 159(4):388-96. PubMed ID: 11823891 [TBL] [Abstract][Full Text] [Related]
13. d-fenfluramine's effects on normal ingestion assessed with taste reactivity measures. Gray RW; Cooper SJ Physiol Behav; 1996 Jun; 59(6):1129-35. PubMed ID: 8737903 [TBL] [Abstract][Full Text] [Related]
14. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine. Currie PJ; Coscina DV; Fletcher PJ Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586 [TBL] [Abstract][Full Text] [Related]
15. Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. Lucas JJ; Yamamoto A; Scearce-Levie K; Saudou F; Hen R J Neurosci; 1998 Jul; 18(14):5537-44. PubMed ID: 9651234 [TBL] [Abstract][Full Text] [Related]
16. Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy? Roth JD; Rowland NE Eur J Pharmacol; 1999 Jun; 373(2-3):127-34. PubMed ID: 10414430 [TBL] [Abstract][Full Text] [Related]
17. The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection. Miller DB; O'Callaghan JP Ann N Y Acad Sci; 1993 May; 679():321-4. PubMed ID: 8099774 [No Abstract] [Full Text] [Related]
18. Fluoxetine prevents the disruptive effects of fenfluramine on differential-reinforcement-of-low-rate 72-second schedule performance. Richards JB; Sabol KE; Seiden LS J Pharmacol Exp Ther; 1993 Dec; 267(3):1256-63. PubMed ID: 8263788 [TBL] [Abstract][Full Text] [Related]
19. Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat. Schaefer TL; Ehrman LA; Gudelsky GA; Vorhees CV; Williams MT J Neurochem; 2006 Sep; 98(5):1369-78. PubMed ID: 16923155 [TBL] [Abstract][Full Text] [Related]
20. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]